1. Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.81
Figure 1 Timeline showing the founding of European biologics registers for rheumatoid arthritis
Figure 1 | Timeline showing the founding of European biologics registers for rheumatoid arthritis. Registers are listed alphabetically. AIR, Autoimmunity and Rituximab; ARTIS, Antirheumatic Therapies in Sweden; ATTRA, Czech National Registry of Patients Treated with Anti-TNF Drugs; BIOBADASER, Base de Datos de Productos Biológicos de la Sociedad Española de Reumatología; BIOROSS, Russian National Biologic Registry; BioRx, Slovenian National Biologic Registry; BSRBR, British Society for Rheumatology Biologics Register; DANBIO, Danish National Registry for Biologic Therapy; DREAM, Dutch Rheumatoid Arthritis Monitoring Registry; ERSBR, Estonian Society for Rheumatology Biologics Register; GISEA, Grupo Italiano di Studio Sulla Early Arthritis; HeRBT, Hellenic Registry for Biologic Therapies; HU‑REGA, Hungarian National Biologic Registry; HÜR-BIO, Hacettepe University Rheumatology Biologic Registry; ICEBIO, Iceland National Biologics Registry; LORHEN, Lombardy Rheumatology Network; MIRA, MabThera in Rheumatoid Arthritis; NARRAS, National Registry of Patients with Rheumatoid Arthritis; NOR-DMARD, Norwegian Disease-Modifying Antirheumatic Drug Registry; ORA, Orencia in Rheumatoid Arthritis; RABBIT, Rheumatoid Arthritis Observation of Biologic Therapy; RATIO, Research Axed on Tolerance of Biotherapies; REGATE, Longitudinal Study on Patients with Rheumatoid Arthritis and Study on Tolerance and Efficacy of Tocilizumab (also known as REGistry- RoAcTEmra); Reuma.pt, The Rheumatic Diseases Portuguese Register; ROB-FIN, National Register of Biologic Treatment in Finland; SCQM‑RA, Swiss Clinical Quality Management Programme for Rheumatoid Arthritis.
Nikiphorou, E. et al. (2017) Biologics registers in RA: methodological aspects, current role and future applications
Nat. Rev. Rheumatol. doi: /nrrheum